Tyler Shultz Headshot
Report a problem with this profile
[email protected]

Tyler Shultz  

Theranos Whistleblower & CEO at Flux Biosciences, Inc.

Tyler Shultz was the first person to alert regulators that something was wrong at Theranos. He sent a complaint about the company potentially manipulating its quality-control checks to the New York state public health lab with a pseudonym. Shultz also spoke confidentially to Wall Street Journal reporter John Carreyrou who wrote a series of stories detailing issues with Theranos' blood testing technology.

He was also on the Lead Stanford team in the Qualcomm Tricorder Xprize Competition, winning the Bold Epic Innovator Award and has worked with Professor Wang for 2+ years, where they filed a joint patent “Small Molecule Magnetic Immunoassays.” In 2016, Forbes named Tyler as one of the 30 most influential people under the age of 30 in healthcare.

Shultz is now working on a new project: the equivalent of a breathalyzer for pot, which will allow law enforcement officers to detect high levels of marijuana's active ingredient, THC, in small samples of saliva.

Speech Topics


An Afternoon with Tyler Shultz

News


Forbes

After Blowing The Whistle On Theranos, Tyler Shultz Is Going Back Into Medical Testing

Flux Biosciences

Flux Biosciences is a company spun out of Stanford University, where the technology used to read and write computer hard drives has been repurposed to perform sensitive and quantitative point-of-care in vitro medical diagnostics. This technology uses blood, urine, or saliva to measure biomarkers related to exercise, stress, fertility, and diet and will correlate those measurements to sleep and activity data collected from wearable technologies.

Related Speakers View all


More like Tyler